搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
财富中文网
11 天
[美国500强] 2024年 第154位:吉利德科学公司(Gilead Sciences)
吉利德科学公司(Gilead Sciences, Inc.)研究、开发用于治疗病毒性疾病的疗法和处理方法,并将其商业化。它的产品包括用于治疗人体免疫缺损病毒感染的Viread、Emriva与Truvada;用于治疗慢性乙型肝炎病毒感染的Hepsera;用于治疗真菌感染的AmBisome;用于治疗巨细..
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Secret Service admits failure
Actress Crosby dies at 90
Ga. suspect's mom indicted
Russia threatens retaliation
Feds subpoena Schaeffer
Rejects CNN debate invite
Pandas leaving for China
Hiker injured in bear attack
House repeals emission rules
Released after guilty plea
Drug price challenge revived
Boeing defense chief exits
$230 million crypto theft
Biden hosts 'Quad' summit
WI high court to decide
FDA approves flu vaccine
1st rabies outbreak in seals
Sues pharmacy middlemen
144K+ Mavericks recalled
Sesame Place suit verdict
CA bill to protect kids online
TN abortion law blocked
Top Hezbollah leader killed?
CAH sues for trespassing
SC 1st execution in 13 years
Hand count approved in GA
J&J unit files for bankruptcy
Beirut strike death toll
Bill to boost security OK'd
ISR strike on Gaza school
In-person voting begins
反馈